Sami Rifai

Sami Rifai currently serves as Président at Groupe Novetude Santé since November 2020. Previously, Sami Rifai held the position of DGD at BIM from September 2008 to November 2020, co-founding private equity firm Octant Partenaires and leading multiple successful ventures, including JS Bio group, Compagnie de Bel Air, and Compagnie Hôtelière de Bagatelle. Additional leadership roles include CEO at AMAC (June 2014 - June 2018) and Director at Finama Private Equity (January 2003 - January 2008), with a focus on private equity in the tourism and services sectors. Sami Rifai began a career at Bain & Company as a Senior Consultant (1999 - 2003), later working at Deloitte & Touche as a Senior Auditor (1995 - 1997), and BNP Paribas as an Analyst (1994 - 1995). Sami Rifai holds an MBA in Finance from Columbia Business School and an MBA in Business Administration from EDHEC Business School.